Form 4: Privia Health CFO Mountcastle Boosts Stock Holdings

Sentiment:

Insider Transaction Report


Privia Health Group's EVP & CFO, David Mountcastle, increased his direct beneficial ownership of common stock through restricted stock unit grants and performance unit vesting.

Summary

  • David Mountcastle, Executive Vice President and Chief Financial Officer of Privia Health Group, Inc. (PRVA), reported an increase in his beneficial ownership of the company's common stock.
  • On March 10, 2026, Mountcastle acquired 35,335 shares of common stock, par value $0.01 per share, as restricted stock units under the 2021 Omnibus Incentive Plan.
  • These restricted stock units are scheduled to vest in substantially equal annual installments on the first, second, and third anniversaries of the grant date, contingent on continued service.
  • On March 11, 2026, an additional 42,584 shares of common stock were vested and distributed to Mountcastle, stemming from performance stock units granted on May 9, 2023, for the 2023-2025 performance period.
  • Following these transactions, Mountcastle's direct beneficial ownership increased to 239,822 shares of common stock.
  • Mountcastle also holds an indirect beneficial ownership of 8,695 shares through his spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as increased insider ownership, especially through performance-based vesting, typically indicates management's confidence in the company's future prospects and alignment with shareholder interests.

Positives

  • The EVP & CFO, David Mountcastle, increased his direct beneficial ownership by a total of 77,919 shares, signaling strong insider confidence in the company's future.
  • A significant portion of the acquired shares (42,584) resulted from the vesting of performance stock units, indicating that performance targets for the 2023-2025 period were met.

Future Outlook

The 35,335 restricted stock units acquired on March 10, 2026, are set to vest in substantially equal annual installments over the next three years, subject to continued service.

Industry Context

StockSavvy.ai notes that an increase in insider ownership, particularly by a key executive like the CFO, is often interpreted by the market as a positive signal, reflecting management's confidence in the company's operational performance and strategic direction within the healthcare services industry.

Related Party Transactions

  • David Mountcastle holds 8,695 shares indirectly through his spouse.

Stakeholder Impact

  • Shareholders may view the increased insider ownership as a positive indicator of management's commitment and belief in the company's long-term value, potentially boosting investor confidence.

Next Steps

  • Future vesting of the 35,335 restricted stock units in annual installments on the first, second, and third anniversaries of the March 10, 2026 grant date.

Key Dates

DateDescription
05/09/2023Grant date for performance stock units for the 2023-2025 performance period.
03/10/2026Acquisition of 35,335 restricted stock units under the 2021 Omnibus Incentive Plan.
03/11/2026Vesting and distribution of 42,584 shares underlying performance stock units.
03/12/2026Date the Form 4 filing was signed by attorney-in-fact.

Keywords

Privia Health Group, PRVA, Insider Transaction, Form 4, Executive Compensation, Restricted Stock Units, Performance Stock Units, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.